Day: January 6, 2025

ATLANTA, Jan. 06, 2025 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, science research and development, and systems engineering and integration, today announced that it has been awarded a Governmentwide Acquisition Indefinite Delivery/Indefinite Quantity (“GWAC ID/IQ”) contract to deliver complex professional services and advanced capabilities to various federal agencies. The One Acquisition Solution for Integrated Services (“OASIS+”) contract is an expansive suite that may be used by all federal agencies. The Defense Health Agency, Centers for Disease Control and Prevention, and the Department of Defense are among the major users of this contracting vehicle. This important award has been a long time in the making, with proposals originally...

BEDMINSTER, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) — Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today announced that members of the executive management team will participate in the 2025 ICR Conference in Orlando, FL. The presentation will be on Tuesday, January 14, 2025 at 10:00 a.m. ET. A live webcast and replay will be available on the “Investors” section of the Company’s website at www.freshpet.com. About FreshpetFreshpet’s mission is to improve the lives of dogs and cats through the power of fresh, real food. Freshpet foods are blends of fresh meats, vegetables and fruits farmed locally and made at our Freshpet Kitchens. We thoughtfully prepare our foods using natural ingredients, cooking them in small batches at lower temperatures to preserve the natural goodness of the ingredients. Freshpet...

TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) — Sparton Resources (TSX-SRI-V), (“the Company”), is pleased to announce that news of positive developments continues to flow from China following the signing of Definitive Agreements (the “Agreements”) between the Company’s 9.98%-owned VRB Energy Inc. (“VRB Energy”), a subsidiary of privately held Shanxi Red Sun Co., Ltd. (“Red Sun”), and certain other affiliates, finalizing the terms of the transaction announced previously. The chronology of progress to date is as follows:On October 15, 2024, the parties signed the definitive agreements for the formation of the VRB China joint venture. On October 18, 2024, a ground breaking ceremony was held in Changzi, Shanxi Province, China, marking the construction of a 3GWh capacity vanadium flow battery manufacturing base. On December 11, 2024, the...

Award-Winning Technology to be Showcased at CES® Booth #15758 Yokneam Illit, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), an award-winning pioneer in artificial intelligence (“AI”)-based wearable gesture control technology, announced the general availability of its Mudra® Link, the first neural wristband for Android, macOS and Windows devices. This achievement marks the Company’s continued expansion as the industry pioneer in wearable gesture control, following the new device’s CES® 2025 Innovation Awards recognition in the XR Technologies & Accessories category.Together with the Company’s Mudra Band for Apple devices, itself a CES® Best of Innovation award-winner, the Mudra Link represents a new era of touchless control and interaction. The Mudra...

TEL AVIV, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced today as part of its ongoing collaboration with Clearmind Medicine Inc. (“Clearmind”) (Nasdaq: CMND) (FSE: CWY0), a biotechnology company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated mental health problems, the publication of a European patent application submitted by Clearmind under the European Patent Office for innovative combination therapy of MEAI and N-Acylethanolamines, to binge behavior including alcohol consumption, eating, tobacco consumption, shopping and sexual conduct. Under...

TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical” or the “Company”) announced that its board of directors (the “Board”) has approved grants of stock options (the “Stock Options”) pursuant to the terms of the Omnibus Equity Incentive Plan effective January 2nd, 2025. A total of 1,073,685 Stock Options have been awarded to directors, officers, employees and consultants of the Company. The Stock Options are exercisable at a price of $0.70 CAD per share (being the closing price of the Company’s shares on the TSXV on January 2, 2025) for a period of 10 years from the date of the grant. Of such 1,073,685 Stock Options, the Company’s independent directors Robert Mitchell, Susan Allen and Aaron Davidson were respectively granted 78,877, 51,442 and 102,882 Stock Options, and the Company’s officers...

Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, 6 January 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that management will participate in in a presentation at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. The presentation is scheduled for Wednesday, January 15, 2025, at 8:15 a.m. Pacific Standard Time (PST). The presentation will be webcast live and can be accessed by visiting ‘Events & Presentations’, under ‘Events’, via the ‘Investors’...

Appoints Chief Marketing Officer and Senior Vice President – Sales & Business Development, Battery & Energy Products NEWARK, N.Y., Jan. 06, 2025 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) today announced the appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President – Sales & Business Development, Battery & Energy Products, effective January 6, 2025. As Chief Marketing Officer, Jeff will be responsible for reframing our corporate and brand strategies, providing alignment and accountability throughout the global organization. He will collaborate closely with our sales and engineering teams to develop and execute effective go-to-market strategies, ensuring that Ultralife’s products and solutions meet the evolving needs of our customers. Jeff brings over two...